Skip to main content

Table 1 Clinical and biochemical characteristics between the study groups before and after intervention

From: Effect of a family and interdisciplinary intervention to prevent T2D: randomized clinical trial

Anthropometric Characteristics

Individual Group (n = 65)

Familiar Group (n = 57)

Basal (n = 65)

Month 6 (n = 48)

Month 12 (n = 39)

Basal (n = 57)

Month 6 (n = 42)

Month 12 (n = 32)

Weight (kg)

81.8 ± 17.0

75.4 ± 17.5B

76.7 ± 19.8 C

82.1 ± 18.0

78.5 ± 19.0 E

76.2 ± 15.0 F

BMI (kg/m2)

30.2 ± 5.3

28.3 ± 5.5B

28.9 ± 6.5 C

30.3 ± 5.8

29.2 ± 6.0 E

28.6 ± 4.6F

WC (cm)

95.3 ± 12.0

91.5 ± 12.4 B

93.5 ± 13.5

96.2 ± 14.0

92.8 ± 17.4

92.8 ± 10.5

Body fat (%)

34.8 ± 8.3

32.7 ± 8.8 B

35.6 ± 7.6

34.8 ± 8.3

33.6 ± 9.0 E

34.5 ± 9.0

Visceral Index (AU)

11.0 ± 4.8

9.8 ± 4.6B

11.3 ± 4.9

11.3 ± 4.6

11.0 ± 4.7 E

10.6 ±

4.3 F

SBP (mm Hg)

123 ± 16

119 ± 16.7

121 ± 14

116 ± 11

113 ± 12

122 ± 15

Biochemistry Characteristics

Glucose (mg/dl) 0 min

101 ± 10

97 ± 10B

94 ± 10C

104 ± 9

97 ± 11 E

98 ± 8 F

Glucose (mg/dl) 120 min

146 ± 23

131 ± 45B

127 ± 33C

149 ± 27

135 ± 35E

142 ± 33

HbA1c (%)

5.3 ± 0.5

5.4 ± 0.3

5.4 ± 0.3

5.1 ± 0.7

5.5 ± 0.4E

5.4 ± 0.3 F

AUCgluc_OGTT (mg/dl/120 min)

18,398 ± 2403

17,749 ± 3965

17,204 ± 3429

18,597 ± 2611

17,637 ± 3849E

17,237 ± 2792F

Tg (mg/dl)

159 ± 79

135 ± 58

148 ± 58

192 ± 90

167 ± 79

210 ± 164

Total Cholesterol (mg/dl)

181 ± 34

177 ± 35∆H

183 ± 35∆I

197 ± 40

186 ± 38E, ∆H

186 ± 35F∆I

HDL (mg/dl)

40 ± 11

44 ± 13

39 ± 14

42 ± 11

44 ± 16

44 ± 12

LDL (mg/dl)

112 ± 33

108 ± 27

118 ± 32∆I

121 ± 36

108 ± 33E

106 ± 38F, ∆I

Markers of insulin resistance and pancreatic β-cell function

 Matsuda Index

3.9 ± 1.9

4.8 ± 2.6B

4.9 ± 3.0C

3.5 ± 2.3

4.9 ± 3.5E

4.7 ± 3.5F

 HOMA IR

2.9 ± 2.0

2.4 ± 1.9B

2.4 ± 1.7C

3.5 ± 2.0

2.9 ± 3.4

3.1 ± 2.7

 Insulin secretion

0.45 ± 0.20

0.44 ± 0.22

0.49 ± 0.25∆I

0.58 ± 0.38

0.48 ± 0.26

0.50 ± 0.27∆I

 Disposition Index

1.5 ± 0.4

1.8 ± 0.7B

1.9 ± 0.7C∆I

1.5 ± 0.5

1.9 ± 0.9E

1.7 ± 0.5∆I

 Oral Disposition Index

0.11 ± 0.12

0.15 ± 0.18

0.08 ± 0.14

0.13 ± 0.13

0.11 ± 0.12

0.11 ± 0.06

  1. Data presented as means ± standard deviation. A = p < 0.05 between groups at the corresponding time; B = p < 0.05 basal vs month 6 individual group; C = p < 0.05 basal vs month 12 individual group; D = p < 0.05 month 6 vs month 12 individual group; E = p < 0.05 basal vs month 6 familiar group; F = p < 0.05 basal vs month 12 familiar group; G = p < 0.05 month 6 vs month 12 familiar group; ∆H = p < 0.05 for comparison of change between groups from 0 to 6 months; ∆I = p < 0.05 for comparison of change between groups from 0 to 12 months. AU, arbitrary units; AUCgluc_OGTT, area under the glucose curve during oral glucose tolerance test; AUCIns, area under the insulin; BMI, body mass index; HbA1c, Glycated hemoglobin; HDL, high density lipoprotein; HOMA IR, homeostatic model assessment; IR, insulin resistance; LDL, low density lipoprotein; SBP, systolic pression blood; Tg, triglycerides; WC, waist circumference